Small Molecule CMO/CDMO Market Report On Size, Share, Competitive Landscape, And Trends Analysis. EINPresswire/ -- The small molecule CMO/CDMO sector is experiencing robust growth fueled by evolving ...

While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same time ...

Terray Therapeutics, a biotechnology company using artificial intelligence to accelerate the development of small-molecule drugs, said today it has raised $120 million in a Series B fundraise to ...

The "U.S. Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type (Preclinical, Clinical, Commercial), Customer Type, Therapeutic Area, Region, and Segment ...

Small Molecule Drug Development Core Facility (SMDD Core) has the automation equipment, libraries, and experienced personnel to support a wide range of assay ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development continue to face a multitude of obstacles, such as complex methodologies, high ...

Washington, DC, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Today, Incubate launched the "Small Molecules, Big Voices" video series to illustrate the importance of small molecule drugs to patients, investors, ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase 2 ...

SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a foc ...

Life-science researchers are thrilled about the advances made with “small-molecule” medicines. The once humble and ordinary pill has become a delivery vehicle for molecules that can penetrate cell ...